TY - JOUR
T1 - Effects of enkephalin analogs, morphine and naloxone on the behavioral responses of phencyclidine in mice
AU - Hiramatsu, M.
AU - Nabeshima, T.
AU - Furukawa, H.
AU - Kameyama, T.
PY - 1984
Y1 - 1984
N2 - The effects of enkephalin analogs, morphine and naloxone were investigated on phencyclidine (PCP)-induced stereotyped behaviors and motor incoordination in mice. Enkephalin analogs (D-ala2-methionine-enkephalinamide; DAMEA 25 μg/mouse and D-ala2-leucine-enkephalin; DALE 12,5 μg/mouse, i.c.v.) significantly increased the degree and duration of pivotting at 10 mg/kg PCP. Morphine (2.5 and 5.0 mg/kg) also potenciated PCP-induced pivotting. On the contrary, naloxone (5.0 mg/kg) partially antagonized PCP-induced pivotting. PCP-induced motor incoordination was enhanced by DAMEA (25 μg/mouse), Dale (12.5 μg/mouse) and morphine (2.5 μg/kg), but not naloxone (5.0 mg/kg). These resuls suggest that an involvement of central opioid receptor mechanisms in the mediation of PCP-induced behaviours in mice.
AB - The effects of enkephalin analogs, morphine and naloxone were investigated on phencyclidine (PCP)-induced stereotyped behaviors and motor incoordination in mice. Enkephalin analogs (D-ala2-methionine-enkephalinamide; DAMEA 25 μg/mouse and D-ala2-leucine-enkephalin; DALE 12,5 μg/mouse, i.c.v.) significantly increased the degree and duration of pivotting at 10 mg/kg PCP. Morphine (2.5 and 5.0 mg/kg) also potenciated PCP-induced pivotting. On the contrary, naloxone (5.0 mg/kg) partially antagonized PCP-induced pivotting. PCP-induced motor incoordination was enhanced by DAMEA (25 μg/mouse), Dale (12.5 μg/mouse) and morphine (2.5 μg/kg), but not naloxone (5.0 mg/kg). These resuls suggest that an involvement of central opioid receptor mechanisms in the mediation of PCP-induced behaviours in mice.
UR - http://www.scopus.com/inward/record.url?scp=0021675315&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021675315&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0021675315
SN - 0193-0818
VL - 5
SP - 161
EP - 173
JO - Research Communications in Substances of Abuse
JF - Research Communications in Substances of Abuse
IS - 3
ER -